Covered recipient · General Payments record
KATHERINE RACHEL BROUWER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$393.26
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.16 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Galderma Laboratories, L.P. | $149.72 | 2 |
| Teva Pharmaceuticals USA, Inc. | $76.62 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.98 | 1 |
| Lilly USA, LLC | $20.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.98 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118055695 | CMS |
| Galderma Laboratories, L.P. | $124.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145345923 | CMS |
| Galderma Laboratories, L.P. | $24.73 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145345925 | CMS |
| Lilly USA, LLC | $20.84 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135649317 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151743360 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.68 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151743374 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.45 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151743408 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.49 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151743460 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.